(19)
(11) EP 4 031 122 A1

(12)

(43) Date of publication:
27.07.2022 Bulletin 2022/30

(21) Application number: 20866500.0

(22) Date of filing: 05.08.2020
(51) International Patent Classification (IPC): 
A61K 31/155(2006.01)
A61K 9/20(2006.01)
 A61K 31/351(2006.01)
A61P 3/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 3/10; A61K 31/155; A61K 9/0007; A61K 9/2018; A61K 31/70
 
C-Sets:
  1. A61K 31/70, A61K 2300/00;
  2. A61K 31/155, A61K 2300/00;
(86) International application number:
PCT/TR2020/050687
(87) International publication number:
WO 2021/054912 (25.03.2021 Gazette 2021/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 16.09.2019 TR 201914043

(71) Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
34460 Sariyer/Istanbul (TR)

(72) Inventors:
  • TASKIN, Abdullah
    34460 Sar yer/Istanbul (TR)
  • DEDEOGLU, Yavuz
    34460 Sar yer/Istanbul (TR)
  • ULUSOY BOZYEL, Muge
    34460 Sar yer/Istanbul (TR)

(74) Representative: Sevinç, Erkan 
Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) EFFERVESCENT TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND METFORMIN